☰

Bryan W. Newman, Ph.D. - Publications

Affiliations: 
2012 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Pharmacy, Pharmacology, Medicine and Surgery, Oncology, Cell Biology
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Burnett JP, Korkaya H, Ouzounova MD, Jiang H, Conley SJ, Newman BW, Sun L, Connarn JN, Chen CS, Zhang N, Wicha MS, Sun D. Trastuzumab resistance induces EMT to transform HER2(+) PTEN(-) to a triple negative breast cancer that requires unique treatment options. Scientific Reports. 5: 15821. PMID 26522776 DOI: 10.1038/Srep15821  0.704
2013 Burnett J, Korkaya H, Newman B, Conley S, Connarn J, Sun L, Lee H, Ouzounova M, Wicha M, Sun D. Abstract 913: Natural product sulforaphane selectively inhibits breast cancer stem cells in basal and trastuzumab resistant Her2+ breast cancer. Cancer Research. 73: 913-913. DOI: 10.1158/1538-7445.Am2013-913  0.741
2012 Newman B, Liu Y, Lee HF, Sun D, Wang Y. HSP90 inhibitor 17-AAG selectively eradicates lymphoma stem cells. Cancer Research. 72: 4551-61. PMID 22751135 DOI: 10.1158/0008-5472.Can-11-3600  0.665
2012 Burnett J, Newman B, Sun D. Targeting cancer stem cells with natural products. Current Drug Targets. 13: 1054-64. PMID 22594473 DOI: 10.2174/138945012802009062  0.683
2012 Conley SJ, Gheordunescu E, Kakarala P, Newman B, Korkaya H, Heath AN, Clouthier SG, Wicha MS. Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia Proceedings of the National Academy of Sciences of the United States of America. 109: 2784-2789. PMID 22308314 DOI: 10.1073/Pnas.1018866109  0.711
2011 Newman BW, Zhang Q, Lu Y, Zhai J, Ding Y, Ma W, Fan H, Long J, Zhang H, Wang M, Chen Y, Sun D. Abstract 3350: Inhibition of breast cancer and cancer stem cells via a novel micheliolide analogue CY-9 Cancer Research. 71: 3350-3350. DOI: 10.1158/1538-7445.Am2011-3350  0.747
2010 Zhang T, Li Y, Zhu Z, Gu M, Newman B, Sun D. MEK inhibition potentiates the activity of Hsp90 inhibitor 17-AAG against pancreatic cancer cells. Molecular Pharmaceutics. 7: 1576-84. PMID 20669973 DOI: 10.1021/Mp900321A  0.637
2010 Li Y, Zhang T, Korkaya H, Liu S, Lee HF, Newman B, Yu Y, Clouthier SG, Schwartz SJ, Wicha MS, Sun D. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 2580-90. PMID 20388854 DOI: 10.1158/1078-0432.Ccr-09-2937  0.713
2010 Yu Y, Hamza A, Zhang T, Gu M, Zou P, Newman B, Li Y, Gunatilaka AA, Zhan CG, Sun D. Withaferin A targets heat shock protein 90 in pancreatic cancer cells. Biochemical Pharmacology. 79: 542-51. PMID 19769945 DOI: 10.1016/J.Bcp.2009.09.017  0.646
2010 Li Y, Zhang T, Korkaya H, Liu S, Lee H, Newman B, Yu Y, Clouthier S, Schwartz S, Wicha M, Sun D. Abstract 4271: Sulforaphane, a Dietary Component of Broccoli/Broccoli Sprouts, Inhibits Breast Cancer Stem Cells Cancer Research. 70: 4271-4271. DOI: 10.1158/1538-7445.Am10-4271  0.721
Show low-probability matches.